- Lobbying
- pharmaceutical AND care AND management
Lobbying Arrangements Results for 'Pharmaceutical Care Management'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Issues related to patent reform Issues related to Medicare Part B and Part D |
ALLERGAN, INC
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022 Policies to remove barriers to physician prescribing decisions including in H.R. 2630/S.652 - Sa... |
Horizon Therapeutics USA, Inc. (formerly known as Horizon Pharma USA, Inc.)
|
THE MCMANUS GROUP | |||
Details Public Law 111-148, the Patient Protection and Affordable Care Act - Implementation issues related to Medicare and Medicaid reimbursement for biotherapeutics, comparative effectiveness research, an... |
Genentech, Inc.
|
Tarplin Strategies LLC | |||
Details Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits S.652 - Safe Step Act S.1038 - Drug Pr... |
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
|
in-house lobbying | |||
Details Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, mental health, opioid abuse, 340B Program, drug pricing, importation of biopharmaceuticals, insulin price c... |
Takeda Pharmaceuticals America, Inc.
|
Crossroads Strategies, LLC | |||
Details Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, 340B Program, drug pricing, importation of biopharmaceuticals, insulin price cap, and international pharmac... |
Bristol-Myers Squibb
|
Crossroads Strategies, LLC | |||
Details Issues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169). Issues related to vaccine development and distribution. Issues related to insulin pr... |
Pharmaceutical Research and Manufacturers of America
|
MARSHALL & POPP, LLC | |||
Details S 765/HR 1526: Reducing Hereditary Cancer Act of 2023- provide hereditary cancer genetic testing Increasing access to telehealth S 2016/HR 4189: CONNECT for Health Act- expands access to telehealth... |
ASSOCIATION FOR CLINICAL ONCOLOGY
|
in-house lobbying | |||
Details H.R. 6363 Further Continuing Appropriations and Other Extensions Act of 2024 H.R. 5378 the Lower Costs, More Transparency Act S.3548 - Health Care Prices Revealed and Information to Consumers E... |
KAISER FOUNDATION HEALTH PLAN INC.
|
in-house lobbying | |||
Details H.R.905 - To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biological... |
AMERISOURCEBERGEN CORPORATION
|
CAPITOL HEALTH GROUP, LLC | |||
Details Legislation and policies related to: Physician/nurse practitioner reimbursement Provisions of the Patient Protection & Affordable Care Act (P.L. 111-148) Adoption of recommendations of the Institut... |
American Association of Nurse Practitioners
|
Mason Consulting, LLC | |||
Details Worked on industry concerns related to S. 2543, the Prescription Drug Pricing Reduction Act (PDPRA) of 2019; S.1895, the Lower Health Care Costs Act; and S. 3129 and HR 19, the Lower Costs, More Cu... |
Allergan, Inc. (formerly Actavis, Inc.)
|
The D Major Group | |||
Details S. 2973 - Modernizing and Ensuring PBM Accountability Act - Issues related to the important role PBMs play in keeping drug prices low for public and private employers and their employees. HR 6363... |
Pharmaceutical Care Management Association (PCMA)
|
Nathanson+Hauck | |||
Details Rare Disease Initiatives. Affordable Care Act (ACA) Issues and Enhancements. Medicare / Medicaid issues impacting patients with rare diseases. Inflation Reduction Act Implementation. Pharmaceutical... |
National Organization for Rare Disorders, Inc. (NORD)
|
in-house lobbying | |||
Details Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, 340B Program, drug pricing, importation of biopharmaceuticals, international pharmaceutical supply chain, T... |
Merck & Co., Inc.
|
Crossroads Strategies, LLC | |||
Details Medicare sequester, PAYGO H.R. 2474, Strengthening Medicare for Patients and Providers Act: an annual inflation adjustment to Medicare physician payments S. 1512, CONNECT for Health Act of 2021: T... |
American Society of Anesthesiologists
|
in-house lobbying | |||
Details Issues regarding childrens health care coverage and access to care under Medicaid, CHIP, the Exchanges, and private insurance Issues regarding the annual Notice of Benefit and Payment Parameters... |
NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS (N.A.C.H.)
|
in-house lobbying | |||
Details Lobby members of Congress regarding issues related to telemedicine. Advocate for a stable supply of medications and for mitigation of drug shortages, including lidocaine. Advocate for increased tra... |
American Academy of Dermatology Association
|
in-house lobbying | |||
Details Issues related to health care, the Food and Drug Administration (FDA), 340B Program, influenza, drug pricing, importation of biopharmaceuticals, international pharmaceutical supply chain, education... |
Genentech, Inc.
|
Crossroads Strategies, LLC | |||
Details General issues related to the bio-pharmaceutical sector, innovation, patient access, health care manufacturing, and pandemic preparedness/response. Measures related to U.S. international and corpor... |
Regeneron Pharmaceuticals, Inc.
|
VENN STRATEGIES | |||
Details Proposals to enhance intellectual property protections to meet unmet medical needs, notably research and development of life-saving therapies; proposals to modify the Food Drug and Cosmetic Act whi... |
Allergan USA, Inc.
|
in-house lobbying | |||
Details H.R. 1770, S.2477: Equitable Community Access to Pharmacist Services Act; Clinical trial diversity, health equity; Emergency preparedness and response. PAHPA reauthorization H.R. 4420 and 4421, S... |
McKesson Corporation & affiliates U.S. Oncology and Rx Savings Solutions
|
McKesson Corporation & affiliates U.S. Oncology and Rx Savings Solutions (Formerly McKesson Corp) | |||
Details CBO modeling Drug Pricing Fiscal year 2024 Appropriations H.R. 5376, Inflation Reduction Act H.R. 6363, the Further Continuing Appropriations and Other Extensions Act, 2024 Importation Value of Med... |
NOVARTIS
|
in-house lobbying | |||
Details Hill outreach to oppose site-neutral payment cuts; Hill outreach in support of the Acute Hospital Care at Home program; Hill outreach about streamlining prior authorization in Medicare Advantage pl... |
American Hospital Association
|
in-house lobbying | |||
Details International trade and protection of intellectual property; TRIPS Waiver; the Medical Supply Chain Resiliency Act; compulsory licensing and other IP issues in multiple countries. Advocate on drug ... |
GILEAD SCIENCES, INC.
|
in-house lobbying | |||
Details Educate policymakers on pharmacy issues related to TRICARE and H.R. 2670, S.2226 Fiscal Year 2024 National Defense Authorization Act; issues related to removing barriers to biosimilar medicine acce... |
CIGNA Corporation
|
Invariant LLC | |||
Details Issues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169). Issues related to vaccine development, distribution and injury compensation. Issues... |
Sanofi U.S. Services, Inc.
|
MARSHALL & POPP, LLC | |||
Details Discussions regarding drug pricing and supply chain issues, rare diseases, gene therapy and value based arrangements; biosimilar support; Alzheimer's policy, screening and diagnosis, PET scan cover... |
BIOGEN
|
in-house lobbying | |||
Details General diabetes prevention; medication affordability and access; S. 1948/H.R. 3709, Chronic Disease Management Act; issues related to high deductible health plan pre-deductible coverage of treatme... |
Novo Nordisk Inc.
|
ALSTON & BIRD LLP | |||
Details General issues related to Over-The-Counter (OTC) pharmaceutical supply chain. Issues related to Drug Enforcement Administration Pseudoephedrine quotas. Issues related to the expansion of Flexible ... |
Consumer Healthcare Products Association
|
Kountoupes Denham Carr & Reid, LLC | |||
Details Issues related to the Improving Seniors Timely Access to Care Act of 2021; Issues related to Pharmacy Direct and Indirect Remuneration (DIR), including the Contract Year (CY) 2023 Policy and Techni... |
The Cigna Group and subsidiaries (Formerly Cigna Corporation and subsidiaries)
|
in-house lobbying | |||
Details H.R. 485 - Protecting Health Care For All Patients Act of 2023 - Rep. McMorris Rodgers, Cathy - federal programs using prices based on quality-adjusted life years H.R. 824 - Telehealth Benefit Exp... |
AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)
|
in-house lobbying | |||
Details H.R. 4368: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 H.R. 5893: Commerce, Justice, Science, and Related Agencies Appropriations Act... |
Pharmaceutical Research and Manufacturers of America
|
in-house lobbying | |||
Details FDA modernization policy issues Reauthorization of newborn screening programs General issues related to rare disease and orphan drugs General issues related to health equity in rare disease and ... |
AstraZeneca Pharmaceuticals LP
|
in-house lobbying | |||
Details Taxes and Tax Reform R&D Tax Credit: Continue to support extending and making permanent full expensing for R&D expenditures for small businesses. Voiced Support for "American Innovation and Jobs A... |
SMALL BUSINESS & ENTREPRENEURSHIP COUNCIL (SBE COUNCIL)
|
in-house lobbying | |||
Details H.R. 4368: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 H.R. 5893: Commerce, Justice, Science, and Related Agencies Appropriations Act... |
GSK (fka GLAXOSMITHKLINE INC.)
|
in-house lobbying | |||
Details President Bidens Fiscal Year (FY) 2024 Budget (No bill): Proposals in the Biden Administrations FY 2024 budget proposal submitted to Congress, specifically on provisions pertaining to Departments o... |
National Committee to Preserve Social Security and Medicare
|
in-house lobbying | |||
Details H.R. 2670/S. 2226, National Defense Authorization Act for Fiscal Year 2024 H.R. 6131, Commercial Space Act of 2023 Draft legislation regarding Department of Commerce Office of Space Commerce missi... |
Chamber of Commerce of the U.S.A.
|
in-house lobbying |